Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers Source: Eur Respir J 2001; 18: 780-783 Year: 2001
Peak inspiratory flow rates in COPD patients with Easyhaler® dry powder inhaler Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009
Peak inspiratory flow (PIF) when using a dry powder inhaler in asthmatics and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 99s Year: 2001
Asthmatic children generate significantly different peak inspiratory flow rates (PIFR) through two different dry powder inhalers (DPI) Source: Eur Respir J 2003; 22: Suppl. 45, 494s Year: 2003
Assessment of peak inspiratory flow through dry powder inhalers in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002
Peak inspiratory flow in COPD: implications for the use of dry powder inhalers Source: Eur Respir J 2001; 18: Suppl. 33, 134s Year: 2001
Severe asthmatic patients generate significantly different peak inspiratory flows (PIF) through two different dry powder inhalers (DPI) Source: Eur Respir J 2004; 24: Suppl. 48, 308s Year: 2004
COPD patients generate significantly different peak inspiratory flows (PIF) through two different dry powder inhalers (DPI) Source: Eur Respir J 2004; 24: Suppl. 48, 88s Year: 2004
Significantly different peak inspiratory flows (PIF) through two different dry powder inhalers (DPI) in critical patient groups Source: Eur Respir J 2005; 26: Suppl. 49, 339s Year: 2005
Measurement of inspiratory flow through 3 different dry powder inhalation devices using In-check in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 493s Year: 2001
Peak inspiratory flow rates through placebo dry powder inhaler device in various asthma and COPD patients Source: Annual Congress 2012 - Asthma management Year: 2012
Consider the turbulent energy not inhalation flow when patients use dry powder inhalers (DPIs) Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
In vitro performance characteristics of a novel multi-dose dry powder inhaler Airmax™ at different inspiratory flow rates Source: Eur Respir J 2002; 20: Suppl. 38, 541s Year: 2002
Inspiratory flow patterns with dry powder inhalers (DPIs) of low and medium flow resistance in subjects with pulmonary arterial hypertension (PAH) Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020
Not the mean value of peak inspiratory flow (PIF), but the number of patients who are able to gain minimal and/or optimal peak inspiratory flow with resistence represented dry powder inhaler, is the proper measure of its utility Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001
Peak inspiratory flow measured at different inhaler resistances in patients with asthma Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020
In vitro delivery of formoterol via a novel multi-dose dry powder inhaler, at clinically relevant inspiratory flow rates Source: Eur Respir J 2003; 22: Suppl. 45, 472s Year: 2003
Effect of changes in peak inspiratory flow on the dose of salbutamol delivered by nebulizers under simulated conditions Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD? Year: 2018
Repeatability of peak nasal inspiratory flow rate (PNIF) measurements and its change after administration of 0.05% oxymetazoline Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012
Do dry powder inhalers (DPIs) have a ‘Goldilocks Zone’ of inhalation? In vitro lung deposition of Budesonide/Formoterol (BUD/FORM) DPI with different inhalation profiles Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017